AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
44.41
+1.11 (2.56%)
At close: Dec 5, 2025, 4:00 PM EST
44.35
-0.06 (-0.14%)
After-hours: Dec 5, 2025, 5:01 PM EST
AnaptysBio Employees
AnaptysBio had 136 employees as of December 31, 2024. The number of employees increased by 19 or 16.24% compared to the previous year.
Employees
136
Change (1Y)
19
Growth (1Y)
16.24%
Revenue / Employee
$1,246,081
Profits / Employee
-$622,279
Market Cap
1.23B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANAB News
- 10 days ago - Anaptys Announces Participation in December Investor Conferences - GlobeNewsWire
- 14 days ago - AnaptysBio shares tumble after legal fight with GSK over cancer drug license - Reuters
- 14 days ago - GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties - Benzinga
- 15 days ago - GSK, AnaptysBio Sue Each Other Over Cancer Drug License - WSJ
- 15 days ago - Anaptys Announces $100 Million Stock Repurchase Plan - GlobeNewsWire
- 15 days ago - Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary - GlobeNewsWire
- 23 days ago - AnaptysBio: Maintaining 'Hold' As RA Program Still In Play With ANB033 Advancement - Seeking Alpha
- 25 days ago - AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study - Benzinga